An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Zhang, Xuewu, Gureasko, Jodi, Shen, Kui, Cole, Philip A., Kuriyan, John·2006·Cell
DOI 10.1016/j.cell.2006.05.013

Cited by (1,001)

Items 701–800 of 1,001

  1. The Juxtamembrane Region of EGFR Takes Center Stage
    Stevan R. Hubbard · 2009 · Cell
  2. Structural Stability and Flexibility Direct the Selection of Activating Mutations in Epidermal Growth Factor Receptor Kinase
    Antonella Paladino, Giulia Morra, Giorgio Colombo · 2015 · Journal of Chemical Information and Modeling
  3. Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations
    Hampig Raphaël Kourié, Marie Chaix, Andrea Gombos, P. Aftimos, Ahmad Hussein Awada · 2016 · Expert Opinion on Drug Metabolism & Toxicology
  4. Src homology 2 domains enhance tyrosine phosphorylation in vivo by protecting binding sites in their target proteins from dephosphorylation
    Joshua A. Jadwin, Timothy G. Curran, Adam T. Lafontaine, Forest M. White, Bruce J. Mayer · 2017 · Journal of Biological Chemistry
  5. Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases
    Keppel, Theodore R., Sarpong, Kwabena, Murray, Elisa M., Monsey, John, Zhu, Jian, Bose, Ron · 2017 · Journal of Biological Chemistry
  6. Trastuzumab Blocks the Receiver Function of HER2 Leading to the Population Shifts of HER2-Containing Homodimers and Heterodimers
    Jun Zhao, Nishant Mohan, Ruth Nussinov, Buyong Ma, Wen Jin Wu · 2021 · Antibodies
  7. Fourth-generation EGFR-TKI to overcome C797S mutation: past, present, and future
    Die Zhang, Jumei Zhao, Yue Yang, Qiangfang Dai, Ning Zhang, Zhikuan Mi, Qianqian Hu, Xiaolong Liu · 2025 · Journal of Enzyme Inhibition and Medicinal Chemistry
  8. Recent Advances in Personalized Lung Cancer Medicine
    Ross A. Okimoto, Trever Grant Bivona · 2014 · Personalized Medicine
  9. Reversible cryo-arrest for imaging molecules in living cells at high spatial resolution
    Martín E. Masip, Jan Huebinger, Jens Christmann, Ola Sabet, Frank Wehner, Antonios D. Konitsiotis, Günther R Fuhr, Philippe I. H. Bastiaens · 2016 · Nature Methods
  10. Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
    Jie An, M. Saeed Sheikh · 2019 · Current Cancer Drug Targets
  11. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors
    Jennifer L. Macdonald-Obermann, LINDA JOY PIKE · 2018 · Journal of Biological Chemistry
  12. Isatin-Hydrazones with Multiple Receptor Tyrosine Kinases (RTKs) Inhibitory Activity and In-Silico Binding Mechanism
    Huda S. Al-Salem, Md. Arifuzzaman, Iman S. Issa, A. F. M. Motiur Rahman · 2021 · Applied Sciences
  13. Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors
    Seyed–Omar Zaraei, Rawan M. Sbenati, Nour N. Alach, Hanan S. Anbar, Randa El‐Gamal, Hamadeh Tarazi, Mahmoud K. Shehata, Mohammed S. Abdel‐Maksoud, Chang‐Hyun Oh, Mohammed I. El–Gamal · 2021 · European Journal of Medicinal Chemistry
  14. The epidermal growth factor receptor in healthy pregnancy and preeclampsia
    Luca Clemente, Ian M. Bird · 2022 · Journal of Molecular Endocrinology
  15. Targeting Receptor Tyrosine Kinases in Cancer
    Wolfgang J. Köstler, Christoph Carl Zielinski · 2014 · Springer eBooks
  16. Identification of N-Terminal Lobe Motifs that Determine the Kinase Activity of the Catalytic Domains and Regulatory Strategies of Src and Csk Protein Tyrosine Kinases
    Kezhen Huang, Yuehao Wang, Alexander Brown, Gongqin Sun · 2009 · Journal of Molecular Biology
  17. Computational study of EGFR inhibition: molecular dynamics studies on the active and inactive protein conformations
    Napat Songtawee, M. Paul Gleeson, Kiattawee Choowongkomon · 2012 · Journal of Molecular Modeling
  18. Consequences of Direct Versus Indirect Activation of Epidermal Growth Factor Receptor in Intestinal Epithelial Cells Are Dictated by Protein-tyrosine Phosphatase 1B
    Declan F. McCole, Anh Truong, Michael Bunz, Kim Elaine Barrett · 2007 · Journal of Biological Chemistry
  19. Nanofibrous Lipid Membranes Capable of Functionally Immobilizing Antibodies and Capturing Specific Cells
    Zhengbao Zha, Celine Cohn, Zhifei Dai, Weiguo Qiu, Jinhong Zhang, Xiaoyi Wu · 2011 · Advanced Materials
  20. Oligomerization–function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET microscopy
    Hirotaka Yamashita, Yoshiaki Yano, Kenichi Kawano, Katsumi Matsuzaki · 2015 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  21. Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain
    Yuki Kawasaki, Ayaka Sakimura, Chul Min Park, Rika Tomaru, Tomohiro Tanaka, Tatsuhiko Ozawa, Yue Zhou, Kaori Narita, Hiroyuki Kishi, Atsushi Muraguchi et al. · 2016 · Scientific Reports
  22. The Spatiotemporal Organization of ErbB Receptors: Insights from Microscopy
    Christopher C. Valley, Keith A. Lidke, Diane S. Lidke · 2013 · Cold Spring Harbor Perspectives in Biology
  23. Structural and biochemical basis of Arabidopsis FERONIA receptor kinase-mediated early signaling initiation
    Yanqiong Kong, Jia Chen, Lingli Jiang, Hong Chen, Yanan Shen, Lifeng Wang, Yujie Yan, Huan Zhou, Heping Zheng, Feng Yu et al. · 2023 · Plant Communications
  24. Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators
    Ilaria Marrocco, Yosef Yarden · 2023 · Cancers
  25. Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer
    Meng Wang, Jing Zhao, Lian min Zhang, Hui Li, Jin-Pu Yu, Xiu-Bao Ren, Chang-Li Wang · 2012 · Journal of Cancer Research and Clinical Oncology
  26. Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian Clustering
    Yan Li, Xiang Li, Weiya Ma, Zigang Dong · 2014 · Journal of Chemical Theory and Computation
  27. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence
    Lijuan He, Kalina A. Hristova · 2012 · Scientific Reports
  28. Strategies for Site‐Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags
    Philipp Wolf, Georgina C. Gavins, Annette Gabriele Beck‐Sickinger, Oliver Seitz · 2021 · ChemBioChem
  29. Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
    Takahiro Yoshizawa, Ken Uchibori, Mitsugu Araki, Shigeyuki Matsumoto, Biao Ma, Ryo Kanada, Yosuke Seto, Tomoko Oh‐hara, Sumie Koike, Ryo Ariyasu et al. · 2021 · npj Precision Oncology
  30. Tyrosine Phosphorylation of Mig6 Reduces Its Inhibition of the Epidermal Growth Factor Receptor
    Zhihong Wang, Lily L. Raines, Richard M. Hooy, Heather Roberson, Daniel J. Leahy, Philip A. Cole · 2013 · ACS Chemical Biology
  31. Toward an understanding of the sequence and structural basis of allosteric proteins
    Xiao‐Bai Li, Yingyi Chen, Shaoyong Lu, Zhimin Huang, Xinyi Liu, Qi Wang, Ting Shi, Jian Zhang · 2013 · Journal of Molecular Graphics and Modelling
  32. Endoplasmic reticulum stress and angiogenesis: is there an interaction between them?
    Annelies Paridaens, Debby Laukens, Yves‐Paul Vandewynckel, Stéphanie Coulon, Hans Van Vlierberghe, Anja M. Geerts, Isabelle O. Colle · 2014 · Liver International
  33. A novel perspective on designing the inhibitor of HER2 receptor
    Calvin Yu‐Chian Chen · 2008 · Journal of The Chinese Institute of Chemical Engineers
  34. Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab
    Jeonghee Cho, Adam Joel Bass, Michael S. Lawrence, Kristian Cibulskis, Ahye Cho, Shi-Nai Lee, Mai Yamauchi, Nikhil Wagle, Panisa Pochanard, Nayoung Kim et al. · 2014 · Molecular Cancer
  35. Quantifying the Interaction between EGFR Dimers and Grb2 in Live Cells
    Nuala Del Piccolo, Kalina A. Hristova · 2017 · Biophysical Journal
  36. Molecular systems biology of ErbB1 signaling: bridging the gap through multiscale modeling and high-performance computing
    Andrew Shih, Jeremy E. Purvis, Ravi Radhakrishnan · 1900 · Molecular BioSystems
  37. SpyMask enables combinatorial assembly of bispecific binders
    Claudia L. Driscoll, Anthony H. Keeble, Mark R. Howarth · 2024 · Nature Communications
  38. A View into the Blind Spot: Solution NMR Provides New Insights into Signal Transduction Across the Lipid Bilayer
    Matthew Edwin Call, James Jeiwen Chou · 2010 · Structure
  39. A Brief Perspective of Drug Resistance Toward Egfr Inhibitors: The Crystal Structures of Egfrs and Their Variants
    Haixing Guan, Yongli Du, Ning Yang, Xin Cao · 2017 · Future Medicinal Chemistry
  40. Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
    Ya Gao, Wies Vallentgoed, Pim J. French · 2018 · Cancers
  41. Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor–associated kinase 4 (IRAK4)
    Li Wang, Ryan Ferrao, Qiubai Li, John M. Hatcher, Hwan Geun Choi, Sara J. Buhrlage, Nathanael S. Gray, Hao Wu · 2019 · Journal of Biological Chemistry
  42. Kinase Activation by Small Conformational Changes
    Elias Daniel Lopez, Osvaldo Burastero, Juan Pablo Arcon, Lucas A. Defelipe, Natalie G. Ahn, Marcelo Adrian Marti, Adrian Gustavo Turjanski · 2019 · Journal of Chemical Information and Modeling
  43. Structural Characterization of the Aurora Kinase B “DFG-flip” Using Metadynamics
    Naga Rajiv Lakkaniga, Meenakshisundaram Balasubramaniam, Shuxing Zhang, Brendan Frett, Hongyu Li · 2019 · The AAPS Journal
  44. Single-molecule functional anatomy of endogenous HER2-HER3 heterodimers
    Byoungsan Choi, Minkwon Cha, Gee Sung Eun, Dae Hee Lee, Seul Lee, Muhammad Ehsan, Pil Seok Chae, Won Do Heo, YongKeun Park, Tae‐Young Yoon · 2020 · eLife
  45. Introducing a pyrazolopyrimidine as a multi-tyrosine kinase inhibitor, using multi-QSAR and docking methods
    Asrin Bahmani, Hamid Tanzadehpanah, Neda Hosseinpour Moghadam, Massoud Saidijam · 2020 · Molecular Diversity
  46. Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer
    Laura C. Zanetti-Domingues, Scott E. Bonner, R. Sumanth Iyer, Marisa L. Martin-Fernandez, Veronica Huber · 2020 · Cells
  47. Growth factor–dependent ErbB vesicular dynamics couple receptor signaling to spatially and functionally distinct Erk pools
    Yannick Brüggemann, Lisa Sophia Karajannis, Angel Stanoev, Wayne Stallaert, Philippe I. H. Bastiaens · 2021 · Science Signaling
  48. PDGFR dimer-specific activation, trafficking and downstream signaling dynamics
    Madison A. Rogers, Maria B. Campaña, Robert Long, Katherine A. Fantauzzo · 2022 · Journal of Cell Science
  49. Fine Details of IGF-1R Activation, Inhibition, and Asymmetry Determined by Associated Hydrogen /Deuterium-Exchange and Peptide Mass Mapping
    Damian J. Houde, Stephen J. Demarest · 2011 · Structure
  50. A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy
    Jeroen Claus, Gargi Surendra Patel, Tony Ng, Peter J. Parker · 2014 · Biochemical Society Transactions
  51. Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
    Toni Michel Brand, Mari Iida, Neha Luthar, Matthew J. Wleklinski, Megan M. Starr, Deric L. Wheeler · 2013 · PLoS ONE · Retracted
  52. Targeting Diverse Signaling Interaction Sites Allows the Rapid Generation of Bivalent Kinase Inhibitors
    Zachary B. Hill, B. Gayani K. Perera, Simeon Andrews, Dustin J. Maly · 2011 · ACS Chemical Biology
  53. Mechanistic and signaling analysis of Muc4–ErbB2 signaling module: New insights into the mechanism of ligand‐independent ErbB2 activity
    Goldi A. Kozloski, Coralie A. Carothers Carraway, Kermit L. Carraway · 2010 · Journal of Cellular Physiology
  54. Oncogenic potential is related to activating effect of cancer single and double somatic mutations in receptor tyrosine kinases
    Kosuke Hashimoto, Igor B. Rogozin, Anna R. Panchenko · 2012 · Human Mutation
  55. Therapeutic targeting of EGFR in malignant gliomas
    Fei Ye, Qinglei Gao, Mingjun Cai · 2010 · Expert Opinion on Therapeutic Targets
  56. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion
    Michael M. Scharl, Ivan Rudenko, Declan F. McCole · 2010 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  57. TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival
    Valda C. Hilliard, Mark R. Frey, Peter J. Dempsey, Richard M. Peek, D. Brent Polk · 2011 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  58. Human Nek6 is a monomeric mostly globular kinase with an unfolded short N-terminal domain
    Gabriela Vaz Meirelles, Júlio César da Silva, Yuri A. Mendonça, Carlos H.I. Ramos, Iris L. Torriani, Jörg Kobarg · 2011 · BMC Structural Biology
  59. Regulation of Protein Kinase C-related Protein Kinase 2 (PRK2) by an Intermolecular PRK2-PRK2 Interaction Mediated by Its N-terminal Domain
    Angelika F. Bauer, Silvina V. Sonzogni, Lucas Meyer, Stefan Zeuzem, Albrecht Piiper, Ricardo M. Biondi, Sonja Neimanis · 2012 · Journal of Biological Chemistry
  60. Cell-free expression of functional receptor tyrosine kinases
    Wei He, Tiffany M. Scharadin, Matthew Saldana, Candice A. Gellner, Steven A. Hoang-Phou, Christina L. Takanishi, Greg L. Hura, John A. Tainer, Kermit L. Carraway, Paul T. Henderson et al. · 2015 · Scientific Reports
  61. Un regard simple sur la biologie du cancer bronchique : EGFR
    Anne-Marie Ruppert, Marie Wislez, Virginie Poulot, Roger Lacave, Martine Antoine, Jacques L. Cadranel · 2011 · Revue des Maladies Respiratoires
  62. Light Sheet Microscopy for Tracking Single Molecules on the Apical Surface of Living Cells
    Yu Li, Ying Hu, Hu Cang · 2013 · The Journal of Physical Chemistry B
  63. Saturation profiling of drug-resistant genetic variants using prime editing
    Younggwang Kim, Hyeong-Cheol Oh, Seung‐Ho Lee, Seokjoong Kim · 2024 · Nature Biotechnology
  64. Positional distribution and conservation of major phosphorylated sites in the human kinome
    Athira Perunelly Gopalakrishnan, Prathik Basthikoppa Shivamurthy, Mukhtar Ahmed, Samseera Ummar, Poornima Ramesh, Sonet Daniel Thomas, Althaf Mahin, Mahammad Nisar, Sowmya Soman, Yashwanth Subbannayya et al. · 2025 · Frontiers in Molecular Biosciences
  65. The Dipole Potential Modifies the Clustering and Ligand Binding Affinity of ErbB Proteins and Their Signaling Efficiency
    Tamás Kovács, Gyula Batta, Tímea Hajdu, Ágnes Szabó, Tímea Váradi, Florina Zákány, István Csomós, János Szöllõsi, Péter Nagy · 2016 · Scientific Reports
  66. Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases
    Janina Niggenaber, Julia Hardick, Jonas Lategahn, Daniel Rauh · 2019 · Journal of Medicinal Chemistry
  67. Recent advances in targeting protein kinases and pseudokinases in cancer biology
    Kristina Riegel, Parthiban Vijayarangakannan, Petros Kechagioglou, Katarzyna Bogucka, Krishnaraj Rajalingam · 2022 · Frontiers in Cell and Developmental Biology
  68. Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics
    Sergio Anastasi, Dante Lamberti, Stefano Alemà, Oreste Segatto · 2015 · Seminars in Cell and Developmental Biology
  69. Role of Network Branching in Eliciting Differential Short‐Term Signaling Responses in the Hypersensitive Epidermal Growth Factor Receptor Mutants Implicated in Lung Cancer
    Jeremy E. Purvis, Vibitha Ilango, Ravi Radhakrishnan · 2008 · Biotechnology Progress
  70. Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment
    Yuji Yamanashi, Tohru Tezuka, K. Yokoyama · 2012 · The Journal of Biochemistry
  71. HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer
    Patrícia M. R. Pereira, Ashwin Ragupathi, Shayla Shmuel, Komal Mandleywala, Nerissa T. Viola, Jason Stuart Lewis · 2019 · Molecular Pharmaceutics
  72. Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
    Mühlenbeck, Henning, Tsutsui, Yuko, Lemmon, Mark A, Bender, Kyle W, Zipfel, Cyril · 2024 · eLife
  73. Kinase Activator-Receiver Preference in ErbB Heterodimers Is Determined by Intracellular Regions and Is Not Coupled to Extracellular Asymmetry
    Matthew D. Ward, Daniel J. Leahy · 2014 · Journal of Biological Chemistry
  74. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants
    Byung Min Chung · 2014 · World Journal of Clinical Oncology
  75. Structural Basis for the Functional Changes by EGFR Exon 20 Insertion Mutations
    Mahlet Z. Tamirat, Kari J. Kurppa, Klaus Elenius, Mark S. Johnson · 2021 · Cancers
  76. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents
    Ankita Pathak, Vivek Parashar Pandey, Yuba Raj Pokharel, Vinod Devaraji, Abuzer Ali, Kashif Haider, Suma Saad, Rikeshwer Prasad Dewangan, Nadeem Siddiqui, Mohammad Shahar Yar · 2021 · Bioorganic Chemistry
  77. EGFR: Tale of the C‐terminal tail
    K.S. Gajiwala · 2013 · Protein Science
  78. The Membrane-proximal Intracellular Domain of the Epidermal Growth Factor Receptor Underlies Negative Cooperativity in Ligand Binding
    Sangeeta Adak, Katherine S. Yang, Jennifer L. Macdonald-Obermann, LINDA JOY PIKE · 2011 · Journal of Biological Chemistry
  79. The Physical Basis of FGFR3 Response to fgf1 and fgf2
    Fenghao Chen, Kalina A. Hristova · 2011 · Biochemistry
  80. Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer
    Chris Papageorgio, Michael C. Perry · 2007 · Cancer Investigation
  81. Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain
    Matheus M de Gunst, Mariëlle I. Gallegos-Ruiz, Giuseppe Giaccone, José Antonio Rodríguez · 2007 · Molecular Cancer
  82. Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
    David J. Riese · 2011 · Expert Opinion on Drug Discovery
  83. Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK
    Clinton A. Taylor, Yu-Chi Angela Juang, Svetlana A. Earnest, Samarpita Sengupta, Elizabeth J. Goldsmith, Melanie H. Cobb · 2015 · Biochemistry
  84. Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
    Chen Hu, Aoli Wang, Hong Wu, Ziping Qi, Xixiang Li, Xiao-E Yan, Chen Cheng, Kailin Yu, Fengming Zou, Wenchao Wang et al. · 2017 · Oncotarget
  85. Chitosan/PEI patch releasing EGF and the EGFR gene for the regeneration of the tympanic membrane after perforation
    Myung Chul Lee, Hoon Seonwoo, Pankaj Garg, Kyoung Je Jang, Shambhavi Pandey, Sang Bae Park, Hong Bae Kim, Jaewoon Lim, Yun‐Hoon Choung, Jong Hoon Chung · 2017 · Biomaterials Science
  86. Identification of Small-Molecule EGFR Allosteric Inhibitors by High-Throughput Docking
    Fabiana Caporuscio, Annachiara Tinivella, Valentina Restelli, Marta Stefania Semrau, Luca Pinzi, Paola Storici, Massimo Broggini, Giulio Rastelli · 2018 · Future Medicinal Chemistry
  87. An unbiased in vitro screen for activating epidermal growth factor receptor mutations
    Deepankar Chakroborty, Kari J. Kurppa, Ilkka Paatero, Veera K. Ojala, Marika K.A. Koivu, Mahlet Z. Tamirat, Jussi Pekka Koivunen, Pasi Antero Janne, Mark S. Johnson, Laura L. Elo et al. · 2019 · Journal of Biological Chemistry
  88. RETRACTED: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase
    Peter Littlefield, Mark M. Moasser, Natalia Jura · 2014 · Chemistry & Biology · Retracted
  89. A novel anti-HER2 antibody GB235 reverses Trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo
    Mengjun Shu, Hongbin Yan, Chuanying Xu, Yan Ping Wu, Zhaohua Chi, Weihong Nian, Zhuzi He, Jing Xiao, Hongli Wei, Qing Zhou et al. · 2020 · Scientific Reports
  90. Phosphorylation-Dependent Conformations of the Disordered Carboxyl-Terminus Domain in the Epidermal Growth Factor Receptor
    Raju Regmi, Shwetha Srinivasan, Andrew P. Latham, Vandna Kukshal, Weidong Cui, Bin Zhang, Ron Bose, Gabriela S. Schlau‐Cohen · 2020 · The Journal of Physical Chemistry Letters
  91. Receptor tyrosine kinase structure and function in health and disease
    Oleg A. Karpov, Gareth W. Fearnley, Gina A. Smith, Jayakanth Kankanala, Michael J. McPherson, Darren Charles Tomlinson, Michael A. Harrison, Sreenivasan Ponnambalam · 2015 · AIMS Biophysics
  92. Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network
    Inka Regine Weingaertner, Sarah Koutnik, Hermann Ammer · 2013 · PLoS ONE
  93. Autoinhibition and Autoactivation of the DNA Replication Checkpoint Kinase Cds1
    Yong-jie Xu, Thomas J. Kelly · 2009 · Journal of Biological Chemistry
  94. Formation and Activity of Template-Assembled Receptor Signaling Complexes
    David J. Montefusco, Anthony L. Shrout, Tatiana Y. Besschetnova, Robert M. Weis · 2007 · Langmuir
  95. Orchestration of ErbB3 signaling through heterointeractions and homointeractions
    Meghan McCabe Pryor, Mara P. Steinkamp, Ádám Halász, Ye Chen, Shujie Yang, Marilyn S. Smith, Gergely Zahoránszky-Köhalmi, Mark F. Swift, XU Xiao-ping, Dorit Hanien et al. · 2015 · Molecular Biology of the Cell
  96. Pockets as structural descriptors of EGFR kinase conformations
    Marcia Anahí Hasenahuer, German Patricio Barletta, Sebastian Fernández-Alberti, Gustavo D. Parisi, Marı́a Silvina Fornasari · 2017 · PLoS ONE
  97. Using molecular simulation to explore the nanoscale dynamics of the plant kinome
    Alexander S. Moffett, Diwakar Shukla · 2018 · Biochemical Journal
  98. In-silico evidences for binding of Glucokinase activators to EGFR C797S to overcome EGFR resistance obstacle with mutant-selective allosteric inhibition
    Harun Patel, Rahul H. Pawara, Sanjay Javerilal Surana · 2018 · Computational Biology and Chemistry
  99. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment
    Wei Wang, Hua Zhao, Teng-Fei Yao, Hao Gong · 2018 · Investigational New Drugs
  100. Principles of Kinase Regulation
    Boštjan Kobe, Bruce E. Kemp · 2010 · Elsevier eBooks